APA (7th ed.) Citation

Ramos, E. L., Dayan, C. M., Chatenoud, L., Sumnik, Z., Simmons, K. M., Szypowska, A., . . . Herold, K. C. (2023). Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes. The New England journal of medicine, 389(23), 2151-2161. https://doi.org/10.1056/NEJMoa2308743

Chicago Style (17th ed.) Citation

Ramos, Eleanor L., et al. "Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes." The New England Journal of Medicine 389, no. 23 (2023): 2151-2161. https://doi.org/10.1056/NEJMoa2308743.

MLA (9th ed.) Citation

Ramos, Eleanor L., et al. "Teplizumab and β-Cell Function in Newly Diagnosed Type 1 Diabetes." The New England Journal of Medicine, vol. 389, no. 23, 2023, pp. 2151-2161, https://doi.org/10.1056/NEJMoa2308743.